Research 2018-06-04T07:53:14+00:00

Innovation

“Any sufficiently advanced technology is indistinguishable from magic.”
Arthur C. Clarke
Contact Us

Upcoming Seminars

Tuesday, June 5th
11, or 2
Wednesday, June 6th
11, 2
Saturday, June 9th
11, 2
Tuesday, June 12th
11, 2, or 7
Wednesday, June 13th
11, 2
Saturday, June 16th
11, 2
Saturday, June 23rd
1

(833) 242-5544

Downloadable Research Documentation 

&

 Published Studies for the Efficacy of Allograft Tissue Products Derived from Birth Tissue (Wharton’s Jelly)

  1. Mesenchymal Stem Cells From Umbilical Cord Tissue Are Best in Clinical Applications

  2. Comparison of Adult and Neonatal Tissue MSCs Hass

  3. MSC Tissue Yield Comparisons Vangsness

  4. Umbilical Cord MSC & Bone Defect Healing Ye

  5. Umbilical Cord vs Blood MSC source Zeddou

  6. Umbilical Cord WJ greatest MSC VANGSNESS

  7. Umbilical Cord WJ viable MSC Watson

  8. WJ MSC Future regenerative med findings and clinical sign Kalaszczynska

  9. Umbilical Cord as Prospective Source for Mesenchymal Stem Cell-Based Therapy

  10. Human Umbilical Cord-Derived Mesenchymal Stem Cells Do Not Undergo Malignant Transformation during Long-Term Culturing in Serum-Free Medium

 11. Batsali, A. Comparative Analysis of Bone Marrow and Wharton’s Jelly Mesenchymal Stem/Stromal Cells. Blood.
2013:122:1212.

 12. Batsali, AK et.al. Mesenchymal stem cells derived from Wharton’s Jelly of the umbilical cord: biological properties and
emerging clinical applications. Current Stem Cell Research and Therapeutics. 2-13 Mar: 8(2): 144-55.

 13. DiMarino, A. et.al. Mesenchymal Stem Cells in Tissue Repair. Frontiers in Immunology. 2013;4:201.

 14. Doi, H. et.al. Potency of umbilical cord blood- and Wharton’s jelly-derived mesenchymal stem cells for scarless wound
healing Scientific Reports 6 :18844(2016).

 15. F Gao et.al. Mesenchymal stem cells and immunomodulation: current status and future prospects Cell Death and
Disease (2016) 7, e2062; doi:10.1038/cddis.2015.327.

 16. Hye, J. et.al. Comparative Analysis of Human Mesenchymal Stem Cells from Bone Marrow, Adipose Tissue, and
Umbilical Cord Blood as Sources of Cell Therapy. International Journal of Molecular Science 2013 Sep: 14(9):
17986-18001.

 17. Hsieh J-Y, Wang H-W, Chang S-J, Liao K-H, Lee I-H, Lin W-S, et al. (2013) Mesenchymal Stem Cells from Human
Umbilical Cord Express Preferentially Secreted Factors Related to Neuroprotection, Neurogenesis, and Angiogenesis.
PLoS ONE 8(8): e72604. doi:10.1371/journal.pone.007260

 18. Kalaszczynska, I and Ferdyn, K. Wharton’s Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine?
BioMed Research International. Vol 2015 article ID 430847.

 19. Liu, Y. et.al. Therapeutic Potential of Human Umbilical Cord Mesenchymal Stem Cells in the Treatment of Rheumatoid
Arthritis. Arthritis Research and Therapeutics. 2010; 12(6): R 210.

 20. Murphy, M. et.al. Mesenchymal stem cells: environmentally responsive therapeutics for regenerative medicine.
Experimental and Molecular Medicine. 2013 Nov; 48(1) e54.

 21. Sobolewski, K. et.al. Wharton’s jelly as a reservoir of peptide growth factors. Placenta. 2005 Nov;26(10):747-52.

 22. Watson, N. et.al. Discarded Wharton’s Jelly of the Human Umbilical Cord: A Viable Source for Mesenchymal Stem
Cells. Cytotherapy. 2015 January; 17(1): 18-24.

 23. Ye, B. et.al. Rapid biomimetic mineralization of collagen fibrils and combining with human umbilical cord mesenchymal
stem cells for bone defects healing. Material Science and Engineering C Material Biology Appl. 2016 Nov 1, 68:
43-51.

 24. Bellamy, et al. Viscosupplementation for the treatment of osteoarthritis of the knee. Cochrane Database Syst Rev.
2006 Apr 19;(2):CD005321

 25. Didier Demesmin, MD Amniotic Fluid as a Homologue to Synovial Fluid: Interim Analysis of Prospective, Multi-Center
Outcome Observational Cohort Registry of Amniotic Fluid Treatment for Osteoarthritis of the Knee Presented at the
2015 AAPM Annual Meeting

 26. Brohlin, et. al, Characterisation of human mesenchymal stem cells following differentiation into Schwann cell-like
cells. Neuroscience Research. 2009, 64(1):41-49.

 27. Chaudhury, S. Mesenchymal stem cell applications to tendon healing. Muscles Ligaments Tendons J. 2012 Jul-Sep;
2(3): 222–229.

 28. Udalamaththa, V. et.al. Potential Role of Herbal Remedies in Stem Cell Therapy: Proliferation and Differentiation of
Human Mesenchymal Stromal Cells Stem Cell Research and Therapy. (2016) 7:110.

 29. Aleynik , et. al. Stem cell delivery of therapies for brain disorders. Clinical and Translational Medicine 2014, 3:24

 30. Li, et. al, Comparative analysis of human mesenchymal stem cells from bone marrow and adipose tissue under
xeno-free conditions for cell therapy. Stem Cell Res Ther. 2015; 6(1): 55.

 31. Anzalone R, et al. Wharton’s jelly mesenchymal stem cells as candidates for beta cells regeneration: extending the
differentiation and immunomodulatory benefits of adult mesenchymal stem cells for the treatment of type 1 diabetes.
Stem Cell Rev. 2011; 7(2):342-63.

 32. Tesche LJ, Gerber DA. Tissue-derived stem and progenitor cells. Stem cells international. 2010; 2010:824876.

 33. Kalaszczynska, et. al, Wharton’s Jelly Derived Mesenchymal Stem Cells: Future of Regenerative Medicine? Recent
Findings and Clinical Significance. Biomed Res Int. 2015; 2015: 430847

RSVP for one of our FREE Seminars

Learn all about stem cells and stem cell therapy, and find out if stem cell therapy may benefit YOU!

FREE 1-hour seminars

Name
Phone Number
Email Address
Seminar Date
Seminar Time
How did you find us?

5 Key Questions You Should Ask Before Getting Treatment